Code for the mRECIST analysis used in:
<br/>Telarovic, I., Yong, C. S. M., Kurz, L., Vetrugno, I., Reichl, S., Sanchez Fernandez, A., Cheng, H. W., Winkler, R., Guckenberger, M., Kipar, A., Ludewig, B., Pruschy, M. Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease. (2024).
<br/>Telarovic, I., Yong, C. S. M., Guckenberger, M., Unkelbach, J. & Pruschy, M. Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model. <i>Neoplasia</i>. 31, 100812 (2022). https://doi.org/10.1016/j.neo.2022.100812
<br/><br/>Adapted from:
<br/>Gao, H. et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. <i>Nat. Med.</i> 21, 1318-1325 (2015). https://doi.org/10.1038/nm.3954
